Satsuma Pharmaceuticals Inc (STSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 12-2017 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,106 | -2,815 | -7,346 | -5,172 | 93,641 |
| Depreciation Amortization | 36 | 60 | 85 | 25 | 43,184 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 37,894 |
| Accounts payable and accrued liabilities | 682 | 913 | N/A | N/A | N/A |
| Other Working Capital | -2,261 | -359 | 295 | 521 | 246,580 |
| Loans | N/A | N/A | N/A | N/A | 318,545 |
| Other Operating Activity | -484 | -859 | -15 | 305 | -327,055 |
| Operating Cash Flow | $-11,133 | $-3,060 | $-6,981 | $-4,321 | $412,789 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -7,403 | N/A | N/A | N/A | N/A |
| PPE Investments | -482 | -22 | -402 | -58 | -19,365 |
| Net Acquisitions | N/A | N/A | 0 | 0 | -150,120 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -322,965 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 399,332 |
| Net Loans | N/A | N/A | N/A | N/A | -709,294 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 64,264 |
| Investing Cash Flow | $-7,885 | $-22 | $-402 | $-58 | $-738,148 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | -5,188 |
| Debt Issued | N/A | N/A | N/A | N/A | 1,875,000 |
| Debt Repayment | N/A | N/A | N/A | N/A | -1,360,158 |
| Common Stock Issued | -56 | 53 | N/A | N/A | 868 |
| Dividend Paid | N/A | N/A | 0 | 0 | -59,195 |
| Other Financing Activity | 61,490 | 0 | 10,930 | 0 | -50,000 |
| Financing Cash Flow | $61,434 | $53 | $10,930 | $0 | $564,169 |
| Beginning Cash Position | 5,205 | 5,205 | 1,658 | 6,037 | 299,878 |
| End Cash Position | 47,621 | 2,176 | 5,205 | 1,658 | 538,688 |
| Net Cash Flow | $42,416 | $-3,029 | $3,547 | $-4,379 | $238,810 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,133 | -3,060 | -6,981 | -4,321 | 412,789 |
| Capital Expenditure | -482 | -22 | N/A | N/A | N/A |
| Free Cash Flow | -11,615 | -3,082 | -6,981 | -4,321 | 412,789 |